Market analyst Ashwani Gujral has recommended BUY trade for two pharmaceutical stocks and SELL trade for two financial services stocks for traders today.

Market analysts Ashwani Gujral has suggested BUY calls for pharmaceutical companies and sell calls for two private banks.

Market analyst Ashwani Gujral has given BUY calls for pharmaceutical majors Cipla and Aurobindo Pharma for today’s trading session. Other stock on Gujral’s BUY list is Jubilant FoodWorks.

Hyderabad: Cipla Ltd will produce the primary three-in-one cocktail anti-AIDS medicine used for children. This accompanies the USFDA clearing a combining quantity of Boehringer Ingelheim’s Viramune, GlaxoSmithKline’s Epivir (or lamivudine) and Bristol-Myers Squibb’s Zerit (or stavudine), which are anti-retrovirals or drugs that fight back AIDS.

The commendation came under the US President’s Emergency Plan for AIDS Relief, or Pepfar, a $15 billion, 5-year plan to clash the threat in over 15 countries.

Cipla dipped 4.4% to Rs 192 after declaring a 30% fall in net earnings for the first quarter ended June 30, 2007.

The stock hit an intraday low of Rs 191.70 and an intraday high of Rs 199.85 during the day.

The scrip turned down on high volume of 21.1 lakh shares on the BSE counter.

The company recorded a 30% fall in its net profit to Rs 120 crore in Q1 June 2007 as against in the corresponding period (Q1 June 2006) of the last year.